Movement Alert|MAO GEPING Falls 5.62% in Regular Trading, Profit-Taking Pressures Stock Despite Solid H1 Earnings

Market Focus08-28

On August 28, MAO GEPING fell 5.62% in regular trading, trading at 49.3 HKD/share, with turnover of approximately 24.25 million HKD.

On the news front, the company released its interim results for the first half of the year. Revenue reached 3.267 billion RMB, up 26.2% year-over-year; attributable net profit rose 20.3% to 805 million RMB; gross margin improved 0.6 percentage points to 84.8%. The board proposed an interim dividend of 0.62 RMB per share. Product sales revenue totaled 3.196 billion RMB, with cosmetics and skincare driving growth of 26.8%, while training services grew 6.6%.

Despite continued double-digit earnings growth, the stock has retreated significantly from its annual high. Southbound capital recorded net selling for five consecutive trading days, with cumulative net reduction of approximately 4.93 million shares, reflecting profit-taking pressure following the earnings release. The broader Personal Products sector also traded lower, with peers including HENGAN INT'L down 0.54%, GIANT BIOGENE down 1.04%, and CHICMAX down 2.4%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment